Buy Cascadian Therapeutics Stock | CASC Stock Price & Latest News | Public.com
CASC

Cascadian Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Cascadian Therapeutics (CASC) stock trends here

    About CASC

    Cascadian Therapeutics, a clinical-stage biopharmaceutical company, researches and develops, and sells therapeutic products for the treatment of cancer in the United States. The company lead clinical-stage product candidate is tucatinib, an orally active and HER2-selec...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Stats

    Market Cap
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High
    1 Year Low
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app